Substance use disorders and the harms associated with these diseases are a serious, growing public health problem in the United States. The U.S. Centers for Disease Control and Prevention estimates that drug overdose deaths increased over 20% in 2021, to total more than 100,000. Three-quarters of these deaths involved opioids.
Despite decades of research establishing methadone as a safe and effective treatment for opioid use disorder, opioid treatment programs (OTPs) remain the only health care facilities allowed to offer this medication.
In 2018, opioid overdoses in the United States caused one death every 11 minutes, resulting in nearly 47,000 fatalities. The most effective treatments for opioid use disorder (OUD) are three medications approved by the Food and Drug Administration (FDA): methadone, buprenorphine, and naltrexone.
Individuals with opioid use disorder (OUD) struggle to get effective care: Of 2 million Americans with the illness, only 26% receive treatment. Now, as the coronavirus pandemic presents an added strain on the U.S. health care system, it is creating greater hardships for those seeking OUD treatment.
Opioid-related overdose deaths and related harms continue to devastate communities across the country, and local resources—including emergency medical services, law enforcement, and health care providers—are under immense strain to respond.
This video is hosted by YouTube. In order to view it, you must consent to the use of “Marketing Cookies” by updating your preferences in the Cookie Settings link below.
This video is hosted by YouTube. In order to view it, you must consent to the use of “Marketing Cookies” by updating your preferences in the Cookie Settings link below.
America’s Opioid Crisis: Outpatient Treatment is Effective and Accessible
More than 2 million Americans suffer from opioid use disorder, but only about 25% of people receive any sort of care. For many, inpatient treatment often means leaving a job and loved ones behind to seek recovery.
Opioid use disorder is a complex brain disease, but it is often still viewed as a moral failing. This stigma can keep people from accessing care for their disease, including medication-assisted treatment (MAT), which combines Food and Drug Administration-approved medications with behavioral therapies. Watch how MAT can help people manage their disease, a critical step in reducing the risk of overdose and improving health.
